Thanks RVXoldtimer and fouremm. I'm trying to get a sense of the value of ZCC at this time and it is clearly low. The TNBC trial has started but at least they are on Pfizer's radar, the mCRPC trial may be analysed by October (will  that research entice other BPs?), the cancer market seems very competitive so it seems like we have quite a journey ahead.

Zenith is going to need money for the trials because the recent raise won't carry them far. It would be a nice dream if they could raise a significant amount in the market but it looks like this will not be viable in the current at the current level.

Looks like private funding will continue until there is a signficant event.

Thanks for the input.

Toinv